	Accessible Clinical Tool for Prognosis and Chemotherapy Prediction in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer in Diverse and Low-Resource Settings. JCO Glob Oncol Peres Moreira RJ, Bines J, Dhungana A, Freeman JQ, Saha P, Sullivan ME, Yao K, Flores EM, Huo D, Pearson AT, Small IA, Olopade OI, Howard FM. PMID: 42214047 [PubMed - indexed for MEDLINE]
	Machine learning models based on magnetic resonance imaging for predicting Lymphovascular Invasion in Invasive Breast Cancer. PLoS One Li H, Huang J, Hou J, Chen X, Zhi C, Li Z. PMID: 42213726 [PubMed - indexed for MEDLINE]
	Statins and risk of cardiovascular disease: Emulating a primary prevention trial in breast cancer survivors. J Natl Cancer Inst Russo RG, Hernán MA, Dahabreh IJ, Rimm EB, Veiga LHS, Hurson AN, Curtis RE, Pfeiffer RM, Booker QS, Corley ME, Mitra PR, Ryerson AB, Honda S, White L, Feigelson HS, Aiello Bowles EJ, Roger VL, Ramin C, Barac A, Gierach GL, Danaei G, Vo JB. PMID: 42213587 [PubMed - as supplied by publisher]
	Correction: Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017. Breast Cancer Tanaka K, Shimomura A, Ishitobi M, Yamanaka T, Tsukioki T, Iwata H, Hara F, Fujisawa T, Sasaki K, Sadachi R, Kajikawa R, Sakai T, Sagara Y, Shigematsu H, Ozaki Y, Nozawa K, Sudo K, Naito Y, Terata K, Ishiba T, Fukuda H, Shien T. PMID: 42213365 [PubMed - as supplied by publisher]
	Health Economic Evaluations of Breast Cancer Screening Strategies: A Systematic Review Focusing on Methodology and Quality Assessment. Appl Health Econ Health Policy Pham TH, de Braak S, van der Werf S, Khoirunnisa SM, Pan X, Pfob A, Wondimu A, van der Schans J, Postma MJ, van Asselt ADI, de Jong LA. PMID: 42213316 [PubMed - as supplied by publisher]
	The Past, Present, and Future of Sentinel Lymph Node Biopsy in Breast Cancer. Ann Surg Oncol Stanczyk M, Cheung TC, Lang JE. PMID: 42213262 [PubMed - as supplied by publisher]
	Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer. Curr Treat Options Oncol Weiner-Gorzel K, McSorley L, Walshe JM. PMID: 42213241 [PubMed - indexed for MEDLINE]
	Diagnostic Value of Coagulation-Fibrinolysis Biomarkers for Metastasis in Lung, Ovarian, Breast, and Colorectal Cancers. Clin Appl Thromb Hemost Zhao Y, Sun X, Lin B, Xu S, Gao H. PMID: 42212702 [PubMed - indexed for MEDLINE]
	Directly comparing randomized and real-world controls in adjuvant breast cancer. J Comp Eff Res Walker B, Boyd M, Silver M, Shi J, Bulsara P, Balanchivadze N, Robert NJ. PMID: 42212589 [PubMed - as supplied by publisher]
	Impact of Dietary Interventions on Health-Related Quality of Life in Women with Breast Cancer Undergoing Chemotherapy and Radiotherapy: A Systematic Review. Nutr Rev Castro-Medina NC, Aguilera-Mendoza MJ, González-Jiménez AS, Gutiérrez-Gómez YY, Aceves-Martins M. PMID: 42212571 [PubMed - as supplied by publisher]
	Association of NF-kappaBIA rs696 gene polymorphism with breast cancer risk in Bangladeshi women: A case-control study. Int J Biol Markers Meem SS, Khan SA, Bhuiyan MA, Islam MS, Islam MR, Mazid MA, Dewan SMR. PMID: 42212517 [PubMed - indexed for MEDLINE]
	Re-evaluating breast malignant pleural effusion: toward evidence-based, precision-aligned care with organoids. Front Bioeng Biotechnol Oliver GR, Jaiswal K, Smythe WR, Barnett CC. PMID: 42212169 [PubMed]
	Patient personas of delayed healthcare-seeking behavior among patients with breast cancer-related lymphedema: A qualitative study. Asia Pac J Oncol Nurs Wang L, Yan S, Xiao R, Chen Y, Cai T, Huang Q, Yang Y, Yuan C. PMID: 42212117 [PubMed]
	Exploring the clinical value of quantitative ultrasound scoring method in optimizing the classification of breast BI-RADS category 4a nodules in the Tibetan Plateau region. Front Oncol Sun M, Yuan D, Liu H, Wang X, Wu X, Xiao R. PMID: 42211509 [PubMed]
	Construction and validation of a prognostic model for seroma after breast cancer surgery: a dual-center retrospective cohort study. Front Oncol Chen Z, Zhou Q, Zhang X, Li C, Li S, Yang G, Xue X, Zhao B. PMID: 42211506 [PubMed]
	MRI-based habitat radiomics for preoperative prediction of axillary pathological complete response in breast cancer after neoadjuvant therapy: a multicenter study. Front Oncol Ma L, Li S, Cao Z, Liao J, Xu M, Lv C, Xu C, Tan H. PMID: 42211502 [PubMed]
	Breast cancer-related endocrine therapy on ocular surface microbiota: mechanism and clinical significance. Int J Ophthalmol Yuan C, Hu XC, Tan RX, Liu C. PMID: 42211223 [PubMed]
	Transcriptionally informed nucleosome profiling of circulating cell-free DNA predicts breast cancer recurrence. Cancer Res Commun Watanabe S, Etoh K, Mitsui J, Suzuki Y, Yamamoto Y, Nakao M. PMID: 42210783 [PubMed - as supplied by publisher]
	Secondary Analysis of the CAN-Study, a Randomised Controlled Trial - Local Anaesthesia and Overall Survival. Acta Anaesthesiol Scand Enlund M, Berglund A, Bergkvist L, CAN. PMID: 42210709 [PubMed - indexed for MEDLINE]
	Circulating tumor DNA in breast cancer: updates from SABCS 2025. J Hematol Oncol Zhi I, Zou X, Sun M, Chan N, Ko N, Vasan N, Ganesan S, Ma C. PMID: 42210387 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 218285

Page 1 of 10915



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy